UVA Researchers Launched MOSAIC Hormonal Study

The project uses computer modeling to investigate how hormonal stages influence individual responses to medication.

Updated on Sept. 26, 2026 in Women’s Health

Isometric editorial illustration showing a complex sculptural molecular structure, representing systemic medical research and biological modeling. — University of Virginia researchers launched the $4 million MOSAIC project to model how gut bacteria and hormonal stages influence individual responses to medication. AI Illustration. Upload story photo >

Live Poll

Do you believe medical treatments should be more customized based on your specific hormonal health?

University of Virginia researchers have launched the MOSAIC project to study how gut bacteria and hormonal stages impact how patients react to drugs. Supported by an initial $4 million grant from the National Institutes of Health, the team aims to create personalized treatment models.

Why it matters

Understanding why medications affect people differently could transform how doctors make individualized treatment decisions. The project seeks to clarify the role of hormonal stages in metabolism, potentially guiding future drug development and prescription standards.

The National Institutes of Health provided an initial $4 million award for the MOSAIC project, with total funding potentially reaching $12 million. Researchers are using these funds to model systems including the gut, liver, and reproductive organs.

The players

University of Virginia

This public research university in Charlottesville serves as the lead institution for the MOSAIC project.

National Institutes of Health

This agency is the primary federal government body responsible for biomedical and public health research in the United States.

The details

The MOSAIC project, or Modeling of Sex-specific metabolism Across Interacting Communities, utilizes large computer models to track how gut bacteria influence estrogen levels. The team is currently testing this approach using bacterial vaginosis, which affects approximately 29% of U.S. women aged 15 to 44, and liver disease.

September 26, 2026: The research project was officially announced.

The Big Picture

The MOSAIC project operates under the precedent of the National Institutes of Health's specialized research programs on sex differences. This study follows the established trend of NIH-funded initiatives that emphasize the necessity of accounting for metabolic sex differences in patient care.

This research may eventually lead to more personalized medication prescriptions that account for a patient's specific hormonal profile. While the study is currently in the modeling phase, findings could eventually improve the efficacy of treatments for common conditions like bacterial vaginosis.

The takeaway

Advancements in computer modeling are increasingly allowing researchers to map complex biological interactions that were previously difficult to track. These tools represent a shift toward precision medicine where treatment plans are customized based on individual metabolic systems.